Ad
related to: myworkdayjobs pfizer
Search results
Results From The WOW.Com Content Network
Workday, Inc., is an American on‑demand (cloud-based) financial management, human capital management, and student information system software vendor. Workday was founded by David Duffield, founder and former CEO of ERP company PeopleSoft, along with former PeopleSoft chief strategist Aneel Bhusri, following Oracle's acquisition of PeopleSoft in 2005.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Pfizer was founded in 1849 as "Charles Pfizer & Company" by Charles Pfizer and Charles F. Erhart, [7] two cousins who had immigrated to the United States from Ludwigsburg, Germany. The business produced chemical compounds, and was headquartered on Bartlett Street [ 8 ] in Williamsburgh, New York where they produced an antiparasitic called ...
In 1996, he was appointed president of the Pfizer International Pharmaceuticals Group, Latin America/Canada. He assumed the position of executive vice president—Europe/Canada in May 2000, added the responsibilities for Africa/Middle East region as of January 2004 and responsibilities for Latin America in March 2006.
Mangipudy said Pfizer produced 3 billion doses of the COVID-19 vaccine in 2021 and expects to produce 4 billion this year, and the company has pledged 2 billion doses to low- and middle-income ...
Pfizergate refers to a scandal involving European Commission President Ursula von der Leyen and the American pharmaceutical company Pfizer over the procurement of COVID-19 vaccines. The controversy centers on the lack of transparency in the communication and negotiation processes for purchasing a significant number of vaccine doses during the ...
From January 2008 to December 2012, if you bought shares in companies when William H. Gray, III joined the board, and sold them when he left, you would have a -17.6 percent return on your investment, compared to a -2.8 percent return from the S&P 500.
Pfizer said it plans to present the data at an upcoming medical meeting and discuss it with global health regulators for a potential approval. The drug is an anti-PD-1 monoclonal antibody, the ...